|
Lasers, Semiconductor
|
D054023 |
[Lasers with a semiconductor diode as the active medium. Diode lasers transform electric energy to light using the same principle as a light-emitting diode (LED), but with internal reflection capability, thus forming a resonator where a stimulated light can reflect back and forth, allowing only a certain wavelength to be emitted. The emission of a given device is determined by the active compound used (e.g., gallium arsenide crystals doped with aluminum or indium). Typical wavelengths are 810, 1,060 and 1,300 nm. (From UMDNS, 2005)
] |
|
Myelencephalon
|
D054024 |
[The most posterior portion of the hindbrain from which MEDULLA OBLONGATA is derived.
] |
|
Cerebrum
|
D054022 |
[Derived from TELENCEPHALON, cerebrum is composed of a right and a left hemisphere. Each contains an outer cerebral cortex and a subcortical basal ganglia. The cerebrum includes all parts within the skull except the MEDULLA OBLONGATA, the PONS, and the CEREBELLUM. Cerebral functions include sensorimotor, emotional, and intellectual activities.
] |
|
Abiotrophia
|
B03.353.750.030.014 |
|
|
Aerococcaceae
|
B03.353.750.030 |
|
|
Paraganglioma, Extra-Adrenal
|
C04.557.580.625.650.700.705 |
|
|
Paraganglioma
|
C04.557.580.625.650.700 |
|
|
Lasers, Dye
|
D054025 |
[Tunable liquid lasers with organic compounds (i.e., dye) which have a strong absorption band, used as the active medium. During emission, the dye has to be optically excited by another light source (e.g., another laser or flash lamp). The range of the emission wavelength may be anywhere from the ultraviolet to the near infrared (i.e., from 180 to 1100nm). These lasers are operated in continuous wave and pulsed modes. (UMDNS, 2005)
] |
|
Hemagglutination, Viral
|
G02.111.026.500.500 |
|
|
Hemagglutination
|
G02.111.026.500 |
|
|
Preventive Psychiatry
|
H02.403.720.750.550 |
|
|
Preventive Medicine
|
H02.403.720.750 |
|
|
Matrix Metalloproteinase 13
|
D08.811.277.656.675.374.525.700.550 |
|
|
Vitamin K 3
|
D02.455.426.559.847.638.721.374.922 |
|
|
Blighia
|
B01.650.940.800.575.912.250.885.111 |
|
|
WAGR Syndrome
|
C16.320.290.078.950 |
|
|
Aniridia
|
C16.320.290.078 |
|
|
Oncogene Protein v-maf
|
D12.776.964.775.750.817 |
|
|
Broadly Neutralizing Antibodies
|
D12.776.377.715.548.114.244.500 |
|
|
Antibodies, Neutralizing
|
D12.776.377.715.548.114.244 |
|
